Elucidating these mechanisms and optimizing their therapeutic efficacy are crucial for effective clinical applications: Mechanisms of Action: 1
Cardiovascular disease affects millions of people worldwide and causes approximately 20 million deaths each year
Studies into the molecular mechanisms underlying the time of day differences post ischemia revealed that ischemic/reperfusion injury at ZT 18 had reduced infarct volume, edema, neurological deficits, apoptotic death, and improved neuronal survival compared to other time points (ZT0, ZT6, ZT12, and ZT18), coinciding with a decrease in PRAS40 and increased expression of Bmal1, Per1, Clock, AKT, Erk-1/2, mTOR, S6 , and BAD ( Disruptions to Circadian Rhythms Influence on Ischemic Stroke (Basic Science) Disruptions to circadian rhythms prior to ischemic events leads to a prothrombotic state resulting in a heightened predisposition for enhanced stroke damage and poor outcome
Extended Duration and Body Weight Reduction Sustained Activation of Target Receptors The 68 day presence of Retatrutide in circulation enables persistent activation of GLP-1, GIP, and glucagon receptors between weekly injections
It completed Phase IIb clinical trials but failed to demonstrate sufficient efficacy for weight loss to secure approval